A Double-blind, Randomized, Controlled, 3-way Crossover, Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2016
At a glance
- Drugs Seltorexant (Primary) ; Zolpidem
- Indications Insomnia; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 23 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 04 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 19 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Feb 2016, as reported by ClinicalTrials.gov.